{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:29:36Z","timestamp":1786364976066,"version":"build-2736575974"},"reference-count":129,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Peking University Third Hospital Fund for Interdisciplinary Research","award":["BMU2025XY033"],"award-info":[{"award-number":["BMU2025XY033"]}]},{"award":["BMU2025XY033"],"award-info":[{"award-number":["BMU2025XY033"]}],"id":[{"id":"https:\/\/ror.org\/04wwqze12","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background: Ocular drug delivery is hindered by the eye\u2019s complex anatomy and multiple physiological barriers. Because of their biocompatibility, biodegradability, and capacity to prolong drug retention, hydrogels have emerged as promising platforms for ocular drug delivery. This study provides a bibliometric and visual analysis of research on hydrogel-based ocular drug delivery from 1991 to 25 August 2025. Methods: Publications were retrieved from the Web of Science Core Collection and screened for relevance. CiteSpace, VOSviewer, and the Bibliometrix R package were used to analyze annual publication trends, contributions and collaborations among countries, institutions, and authors, core journals, and evolving research themes. Results: A total of 1354 publications (991 articles and 363 reviews) were included. Annual output increased markedly after 2007\u20132008, reflecting rapid growth in this field. China and the USA were the leading contributors, and the University of Florida was the most productive institution. Keyword co-occurrence, clustering, and burst analyses identified in situ hydrogels, tissue engineering applications, and anti-VEGF delivery as major research hotspots. Conclusions: This study maps the growth and diversification of hydrogel-based ocular drug delivery research, revealing a shift toward disease- and segment-specific applications, with controlled-release, stimuli-responsive systems, injectable hydrogels, and anti-VEGF as emerging research priorities.<\/jats:p>","DOI":"10.3390\/pharmaceutics18080981","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:38:09Z","timestamp":1786361889000},"page":"981","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hydrogel-Based Ocular Drug Delivery Systems: A Bibliometric and Visualization Analysis of Research Trends and Hotspots (1991\u20132025)"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8755-7087","authenticated-orcid":false,"given":"Linyang","family":"Li","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China"},{"name":"Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[{"name":"Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8753-8086","authenticated-orcid":false,"given":"Xiaotong","family":"Yu","sequence":"additional","affiliation":[{"name":"Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global Prevalence of Age-Related Macular Degeneration and Disease Burden Projection for 2020 and 2040: A Systematic Review and Meta-Analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijbiomac.2018.01.120","article-title":"Biological Macromolecules for Ophthalmic Drug Delivery to Treat Ocular Diseases","volume":"110","author":"Krishnaswami","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ophtha.2022.01.023","article-title":"Alcohol, Intraocular Pressure, and Open-Angle Glaucoma","volume":"129","author":"Stuart","year":"2022","journal-title":"Ophthalmology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","article-title":"Ocular Drug Delivery: A Comprehensive Review","volume":"24","author":"Ahmed","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/17425247.2022.2119220","article-title":"Microneedles for Transdermal Drug Delivery Using Clay-Based Composites","volume":"19","author":"Sabbagh","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sabbagh, F., Khatir, N.M., and Kiarostami, K. (2023). Synthesis and Characterization of k-Carrageenan\/PVA Nanocomposite Hydrogels in Combination with MgZnO Nanoparticles to Evaluate the Catechin Release. Polymers, 15.","DOI":"10.3390\/polym15020272"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"145356","DOI":"10.1016\/j.ijbiomac.2025.145356","article-title":"Fabrication of an Alginate-Poloxamer 407 Thermosensitive Carboxymethyl Chitosan Stabilized Nanosuspension Hydrogel for Enhanced Ocular Delivery of Clobetasol Propionate in Uveitis Management","volume":"319","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"122486","DOI":"10.1016\/j.carbpol.2024.122486","article-title":"Absorption Enhancement Strategies in Chitosan-Based Nanosystems and Hydrogels Intended for Ocular Delivery: Latest Advances for Optimization of Drug Permeation","volume":"343","author":"Dmour","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kim, M., Jung, M.-Y., Lee, D.-Y., Ahn, S.M., Lee, G.M., and Park, C.Y. (2024). How to Fabricate Hyaluronic Acid for Ocular Drug Delivery. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16121604"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"025029","DOI":"10.1088\/1748-605X\/adb555","article-title":"Thiolated Gellan Gum\/Polyethylene Glycol Diacrylate Hydrogels Containing Timolol Maleate-Loaded Chitosan Nanoparticles for Ophthalmic Delivery","volume":"20","author":"Shajari","year":"2025","journal-title":"BioMed Mater."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/0115680266316522241015143856","article-title":"Recent Advances in Multifaceted Drug Delivery Using Natural Polysaccharides and Polyacrylamide-Based Nanomaterials in Nanoformulation","volume":"25","author":"Choudhury","year":"2025","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"14982","DOI":"10.1039\/D5TB01575H","article-title":"Hydrogel-Based Ocular Drug Delivery Systems","volume":"13","author":"Sabbagh","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2019.05.034","article-title":"Hydrogel-Based Ocular Drug Delivery Systems: Emerging Fabrication Strategies, Applications, and Bench-to-Bedside Manufacturing Considerations","volume":"306","author":"Cooper","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2015.05.016","article-title":"Hydrogels in Ophthalmic Applications","volume":"95","author":"Kirchhof","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2017.12.019","article-title":"Antibody Loaded Collapsible Hyaluronic Acid Hydrogels for Intraocular Delivery","volume":"124","author":"Egbu","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2403399","DOI":"10.1002\/advs.202403399","article-title":"Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases","volume":"11","author":"Wu","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jconrel.2022.03.031","article-title":"Bibliometric and Visualized Analysis of Ocular Drug Delivery from 2001 to 2020","volume":"345","author":"Peng","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2004.03.019","article-title":"In Situ-Forming Hydrogels\u2014Review of Temperature-Sensitive Systems","volume":"58","author":"Leroux","year":"2004","journal-title":"Eur.-An. J. Pharm. Biopharm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic Drug Delivery Sys-tems\u2014Recent Advances","volume":"17","author":"Acar","year":"1998","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_20","first-page":"2182","article-title":"Soft Contact Lenses Capable of Sustained Delivery of Timolol","volume":"91","author":"Hiratani","year":"2002","journal-title":"JPharmSci"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-3659(02)00213-4","article-title":"Timolol Uptake and Release by Imprinted Soft Contact Lenses Made of N,N-Diethylacrylamide and Methacrylic Acid","volume":"83","author":"Hiratani","year":"2002","journal-title":"J. Control. Release"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5173(03)00124-8","article-title":"In Vitro Uptake and Release Studies of Ocular Pharma-ceutical Agents by Silicon-Containing and p-HEMA Hydrogel Contact Lens Materials","volume":"257","author":"Karlgard","year":"2003","journal-title":"Int. J. Pharm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1167\/iovs.03-0959","article-title":"Ophthalmic Drug Delivery through Contact Lenses","volume":"45","author":"Gulsen","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.biomaterials.2004.04.030","article-title":"Ocular Release of Timolol from Mo-lecularly Imprinted Soft Contact Lenses","volume":"26","author":"Hiratani","year":"2005","journal-title":"Biomaterials"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The Use of Mucoadhesive Polymers in Ocular Drug Delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2004.11.033","article-title":"Dispersion of Microemulsion Drops in HEMA Hydrogel: A Potential Ophthalmic Drug Delivery Vehicle","volume":"292","author":"Gulsen","year":"2005","journal-title":"Int. J. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ie0507934","article-title":"Modeling Ophthalmic Drug Delivery by Soaked Contact Lenses","volume":"45","author":"Li","year":"2006","journal-title":"Ind. Eng. Chem. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2006.05.003","article-title":"Imprinted Soft Contact Lenses as Norfloxa-cin Delivery Systems","volume":"113","author":"Concheiro","year":"2006","journal-title":"J. Control. Release"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2007.09.006","article-title":"Zero-Order Therapeutic Release from Imprinted Hydrogel Contact Lenses within in Vitro Physiological Ocular Tear Flow","volume":"124","author":"Ali","year":"2007","journal-title":"J. Control. Release"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.biomaterials.2008.01.030","article-title":"Extended Delivery of Ophthalmic Drugs by Silicone Hydrogel Contact Lenses","volume":"29","author":"Kim","year":"2008","journal-title":"Biomaterials"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1167\/iovs.08-2826","article-title":"A Drug-Eluting Con-tact Lens","volume":"50","author":"Ciolino","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s11095-008-9818-6","article-title":"Controlled Release of High Molecular Weight Hyaluronic Acid from Molecularly Im-printed Hydrogel Contact Lenses","volume":"26","author":"Ali","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent Perspectives in Ocular Drug Delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.biomaterials.2008.10.032","article-title":"Surfactant-Laden Soft Contact Lenses for Extended Delivery of Ophthalmic Drugs","volume":"30","author":"Kapoor","year":"2009","journal-title":"Biomaterials"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1016\/j.biomaterials.2010.01.113","article-title":"Extended Delivery of Hydrophilic Drugs from Silicone-Hydrogel Contact Lenses Containing Vitamin E Diffusion Barriers","volume":"31","author":"Peng","year":"2010","journal-title":"Biomaterials"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular Drug Delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jconrel.2012.10.010","article-title":"Glaucoma Therapy by Extended Release of Timolol from Nanoparticle Loaded Silicone-Hydrogel Contact Lenses","volume":"165","author":"Jung","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.3109\/10717544.2016.1138342","article-title":"A Review on Therapeutic Contact Lenses for Ocular Drug Delivery","volume":"23","author":"Maulvi","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.exer.2006.02.010","article-title":"Pegaptanib for the Treatment of Age-Related Macular Degeneration","volume":"83","author":"Zhou","year":"2006","journal-title":"Exp. Eye Res."},{"key":"ref_40","first-page":"206\u2013213; discussion 213-214","article-title":"Thermoresponsive Hydrogels as a New Ocular Drug Delivery Platform to the Posterior Segment of the Eye","volume":"106","author":"Mieler","year":"2008","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"115006","DOI":"10.1016\/j.addr.2023.115006","article-title":"Recent Advances of Smart Materials for Ocular Drug Delivery","volume":"200","author":"Wang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/17425247.2023.2166927","article-title":"Intraocular Delivery Considerations of Ocular Biologic Products and Key Preclinical Determinations","volume":"20","author":"Hughes","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0163-7258(82)90017-1","article-title":"Drug Delivery to the Eye","volume":"17","author":"Chiou","year":"1982","journal-title":"Pharmacol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Wu, K.Y., Akbar, D., Giunta, M., Kalevar, A., and Tran, S.D. (2023). Hydrogels in Ophthalmology: Novel Strategies for Overcoming Therapeutic Challenges. Materials, 17.","DOI":"10.3390\/ma17010086"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e20230021","DOI":"10.1002\/smo.20230021","article-title":"Smart Molecules in Ophthalmology: Hydrogels as Responsive Systems for Ophthalmic Applications","volume":"2","author":"Kulbay","year":"2024","journal-title":"Smart Mol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Tsung, T.-H., Chen, Y.-H., and Lu, D.-W. (2023). Updates on Biodegradable Formulations for Ocular Drug Delivery. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030734"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/cxo.12592","article-title":"Contact Lenses for Ophthalmic Drug Delivery","volume":"100","author":"Hui","year":"2017","journal-title":"Clin. Exp. Optom."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2010.07.119","article-title":"Extended Release of Dexamethasone from Silicone-Hydrogel Contact Lenses Containing Vitamin E","volume":"148","author":"Kim","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/la203606z","article-title":"Transport of Topical Anesthetics in Vitamin E Loaded Silicone Hydrogel Contact Lenses","volume":"28","author":"Peng","year":"2012","journal-title":"Langmuir"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2012.06.017","article-title":"Extended Drug Delivery by Contact Lenses for Glaucoma Therapy","volume":"162","author":"Peng","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejpb.2015.06.001","article-title":"Dual Drug Delivery from Vitamin E Loaded Contact Lenses for Glaucoma Therapy","volume":"94","author":"Hsu","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/02713683.2014.917192","article-title":"Release of Betaine and Dexpanthenol from Vitamin E Modified Silicone-Hydrogel Contact Lenses","volume":"40","author":"Hsu","year":"2015","journal-title":"Curr. Eye Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1517\/13543776.2015.1057501","article-title":"Therapeutic Contact Lenses: A Patent Review","volume":"25","author":"Dixon","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0022-3549(15)00193-8","article-title":"Controlled Release of Antibiotics From Vitamin E-Loaded Silicone-Hydrogel Contact Lenses","volume":"105","author":"Paradiso","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijpharm.2017.11.059","article-title":"In Vitro Drug Release and in Vivo Safety of Vitamin E and Cysteamine Loaded Contact Lenses","volume":"544","author":"Dixon","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jcis.2018.12.036","article-title":"Effect of Vitamin-E Integration on Delivery of Prostaglandin Analogs from Therapeutic Lenses","volume":"539","author":"Sekar","year":"2019","journal-title":"J. Colloid Interface Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"122740","DOI":"10.1016\/j.ijpharm.2023.122740","article-title":"Therapeutic Contact Lenses for the Treatment of Corneal and Ocular Surface Diseases: Advances in Extended and Targeted Drug Delivery","volume":"638","author":"Abdi","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_58","first-page":"100847","article-title":"Contact Lens as an Emerging Platform for Ophthalmic Drug Delivery: A Systematic Review","volume":"18","author":"Yang","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"114817","DOI":"10.1016\/j.addr.2023.114817","article-title":"Smart Contact Lens Systems for Ocular Drug Delivery and Therapy","volume":"196","author":"Kim","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_60","first-page":"423","article-title":"A Hybrid Genipin-Crosslinked Dual-Sensitive Hydrogel\/Nanostructured Lipid Carrier Ocular Drug Delivery Platform","volume":"14","author":"Yu","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Tatke, A., Dudhipala, N., Janga, K.Y., Balguri, S.P., Avula, B., Jablonski, M.M., and Majumdar, S. (2019). In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies. Nanomaterials, 9.","DOI":"10.3390\/nano9010033"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1080\/10717544.2016.1223225","article-title":"Development of Loteprednol Etabonate-Loaded Cationic Nanoemulsified In-Situ Ophthalmic Gel for Sustained Delivery and Enhanced Ocular Bioavailability","volume":"23","author":"Patel","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-5173(82)90114-4","article-title":"Effect of Poloxamer 407 Gel on the Miotic Activity of Pilocarpine Nitrate in Rabbits","volume":"12","author":"Miller","year":"1982","journal-title":"Int. J. Pharm."},{"key":"ref_64","first-page":"130","article-title":"Preliminary-Study of Prolonged Acting Drug Delivery System for the Treatment of Glaucoma","volume":"56","author":"Gurny","year":"1981","journal-title":"Pharm. Acta Helv."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-5173(89)90305-0","article-title":"Gelrite: A Novel, Ion-Activated, In Situ Gelling Polymer for Ophthalmic Vehicles\u2014Effect on Bioavailability of Timolol","volume":"57","author":"Rozier","year":"1989","journal-title":"Int. J. Pharm."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/02652049209021249","article-title":"Polymeric Pseudolatices Bearing Pilocarpine for Controlled Ocular Delivery","volume":"9","author":"Vyas","year":"1992","journal-title":"J. Microencapsul."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jps.2600810704","article-title":"Use of Fluorometry in Assessing the Efficacy of a Cation-Sensitive Gel as an Ophthalmic Vehicle: Comparison with Scintigraphy","volume":"81","author":"Maurice","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/10611869409015908","article-title":"In-Vivo Evaluation of Dosage Forms\u2014Application of Gamma-Scintigraphy to Non-Enteral Routes of Administration","volume":"2","author":"Meseguer","year":"1994","journal-title":"J. Drug Target."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0002-9394(14)70432-5","article-title":"Comparison of the Effects of Aqueous and Gellan Ophthalmic Timolol on Peak Exercise Performance in Middle-Aged Men","volume":"121","author":"Dickstein","year":"1996","journal-title":"Am. J. Ophthalmol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijbiomac.2018.03.117","article-title":"Nanostructured Lipid Carrier-Based pH and Temperature Dual-Responsive Hydrogel Composed of Carboxymethyl Chitosan and Poloxamer for Drug Delivery","volume":"114","author":"Yu","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2024.05.031","article-title":"In Situ Gelling Systems for Ocular Drug Delivery","volume":"371","author":"Ahmed","year":"2024","journal-title":"J. Control. Release"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s42269-023-01123-9","article-title":"Revolutionizing Ocular Drug Delivery: Recent Advancements in In Situ Gel Technology","volume":"47","author":"Paul","year":"2023","journal-title":"Bull. Natl. Res. Cent."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"132086","DOI":"10.1016\/j.ijbiomac.2024.132086","article-title":"Injectable Hydrogels Based on Biopolymers for the Treatment of Ocular Diseases","volume":"269","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2306463","DOI":"10.1002\/advs.202306463","article-title":"Long-Acting Ocular Injectables: Are We Looking In The Right Direction?","volume":"11","author":"Dang","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Giri, B.R., Jakka, D., Sandoval, M.A., Kulkarni, V.R., and Bao, Q. (2024). Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16101325"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"214732","DOI":"10.1016\/j.bioadv.2026.214732","article-title":"Micelle-Integrated Hydrogel Combined with pH-Response Boosts Eye Burns Therapy by Inhibiting Neovascularization, Regulating Inflammation and Bacteriostasis","volume":"183","author":"Li","year":"2026","journal-title":"Biomater. Adv."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"114077","DOI":"10.1016\/j.jconrel.2025.114077","article-title":"Hyaluronic Acid Methacryloyl-Based Co-Delivery System for Aflibercept and miR-21-3p Antagomir: A Dual-Therapeutic Approach for Diabetic Retinopathy","volume":"386","author":"Ni","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"101917","DOI":"10.1016\/j.mtbio.2025.101917","article-title":"Thermosensitive Hydrogel Composite with Si-Cx43 Nanoparticles and Anti-VEGF Agent for Synergistic Treatment of Diabetic Retinopathy","volume":"33","author":"Wen","year":"2025","journal-title":"Mater. Today Bio"},{"key":"ref_79","first-page":"100969","article-title":"Revamping Anti-cGAS-STING Therapy via an Injectable Thermo-Responsive Supramolecular Hydrogel for Pathological Retinal Angiogenesis","volume":"19","author":"Yan","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e23495","DOI":"10.1002\/advs.202523495","article-title":"Dual-Target ROS-Driven Spatiotemporal Senolysis for Vascular Repair and Immune Microenvironment Reprogramming in the Treatment of Ocular Fundus Neovascularization","volume":"13","author":"Zhou","year":"2026","journal-title":"Adv. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e00263","DOI":"10.1002\/mabi.202500263","article-title":"Development of Nanoparticle-Hydrogel Drug Delivery System for Sustained Release of Anti-VEGF Peptide in Ocular Neovascularization Treatment","volume":"26","author":"Durak","year":"2026","journal-title":"Macromol. Biosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2024.10.001","article-title":"Dasatinib and Erianin Co-Loaded Ion-Responsive in-Situ Hydrogel for Effective Treatment of Corneal Neovascularization","volume":"376","author":"Lei","year":"2024","journal-title":"J. Control. Release"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"113650","DOI":"10.1016\/j.jconrel.2025.113650","article-title":"High-Efficiency Antioxidant ROS-Responsive Thermosensitive Hydrogel Encapsulated Fenofibrate for the Treatment of Corneal Neovascularization","volume":"382","author":"Fan","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2022.03.011","article-title":"Enzyme-Instructed Self-Assembly of Peptide-Drug Conjugates in Tear Fluids for Ocular Drug Delivery","volume":"344","author":"Hu","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_85","first-page":"3062","article-title":"Injectable Bio-Responsive Hydrogel for Therapy of Inflammation Related Eyelid Diseases","volume":"6","author":"Chen","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1007\/s13346-024-01756-x","article-title":"Recent Updates on Drug Delivery Approaches for Improved Ocular Delivery with an Insight into Nanostructured Drug Delivery Carriers for Anterior and Posterior Segment Disorders","volume":"15","author":"Khan","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/2589977514666220913120718","article-title":"Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives","volume":"15","author":"Kaushal","year":"2023","journal-title":"Curr. Drug Res. Rev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12951-023-01992-2","article-title":"Nanotechnology-Based Ocular Drug Delivery Systems: Recent Advances and Future Prospects","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Lovrec-Krsti\u010d, T., Orthaber, K., Maver, U., and Sarenac, T. (2023). Review of Potential Drug-Eluting Contact Lens Technologies. Materials, 16.","DOI":"10.3390\/ma16103653"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"123819","DOI":"10.1016\/j.ijpharm.2024.123819","article-title":"In-Situ Gel: A Smart Carrier for Drug Delivery","volume":"652","author":"Garg","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Kurniawansyah, I.S., Rusdiana, T., Sopyan, I., Desy Arya, I.F., Wahab, H.A., and Nurzanah, D. (2023). Comparative Study of In Situ Gel Formulation Based on the Physico-Chemical Aspect: Systematic Review. Gels, 9.","DOI":"10.3390\/gels9080645"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/jop.2024.0153","article-title":"Formulation Advances in Posterior Segment Ocular Drug Delivery","volume":"41","author":"Sarkar","year":"2025","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular Endothelial Growth Factor in Eye Disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s13346-025-01925-6","article-title":"Emerging Innovations in Ophthalmic Drug Delivery for Diabetic Retinopathy: A Translational Perspective","volume":"16","author":"Adak","year":"2026","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1167\/iovs.13-13120","article-title":"Biocompatible Reverse Thermal Gel Sustains the Release of Intravitreal Bevacizumab In Vivo","volume":"55","author":"Rauck","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Paliwal, H., Prajapati, B.G., Srichana, T., Singh, S., and Patel, R.J. (2023). Novel Approaches in the Drug Development and Delivery Systems for Age-Related Macular Degeneration. Life, 13.","DOI":"10.3390\/life13020568"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/14712598.2024.2374869","article-title":"Long-Acting Delivery and Therapies for Neovascular Age-Related Macular Degeneration","volume":"24","author":"Rowe","year":"2024","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_98","first-page":"100947","article-title":"Intravitreal Long-Term Sustained Ranibizumab Delivery Using Injectable Microgel-Embedded Hydrogel","volume":"19","author":"Lee","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/24741264241267065","article-title":"Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases","volume":"8","author":"Wykoff","year":"2024","journal-title":"J. Vitreoretin. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Arabpour, Z., Salehi, M., An, S., Moghtader, A., Anwar, K.N., Baharnoori, S.M., Shah, R.J., Abedi, F., and Djalilian, A.R. (2024). Exploring Hydrogel Nanoparticle Systems for Enhanced Ocular Drug Delivery. Gels, 10.","DOI":"10.3390\/gels10090589"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.actbio.2023.12.021","article-title":"A Tissue-Adhesive F127 Hydrogel Delivers Antioxidative Copper-Selenide Nanoparticles for the Treatment of Dry Eye Disease","volume":"175","author":"Ou","year":"2024","journal-title":"Acta Biomater."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Yang, N., Mu, J., Xu, F., Guo, W., Sun, C., Peng, B., Xiang, J., Deng, L., and Fan, W. (2026). Advances in Dry Eye Disease: From Immunopathological Mechanisms to Emerging Ophthalmic Drug Delivery Systems. Front. Med., 13.","DOI":"10.3389\/fmed.2026.1780733"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jconrel.2023.07.036","article-title":"Inflammation-Responsive Molecular-Gated Contact Lens for the Treatment of Corneal Neovascularization","volume":"360","author":"Sun","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"103354","DOI":"10.1016\/j.redox.2024.103354","article-title":"Phytic Acid-Loaded Polyvinyl Alcohol Hydrogel Promotes Wound Healing of Injured Corneal Epithelium through Inhibiting Ferroptosis","volume":"76","author":"Gong","year":"2024","journal-title":"Redox Biol."},{"key":"ref_105","first-page":"100477","article-title":"Hydrogel-Encapsulated Antioxidant Nanotherapeutics against Age-Related Macular Degeneration (AMD) Oxidative Damage","volume":"11","author":"Xu","year":"2026","journal-title":"Int. J. Pharm. X"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e2308635","DOI":"10.1002\/advs.202308635","article-title":"Injectable, Antioxidative, and Tissue-Adhesive Nanocomposite Hydrogel as a Potential Treatment for Inner Retina Injuries","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_107","first-page":"420","article-title":"Drug-Peptide Supramolecular Hydrogel Boosting Transcorneal Permeability and Pharmacological Activity via Ligand-Receptor Interaction","volume":"10","author":"Chen","year":"2022","journal-title":"Bioact. Mater."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.actbio.2023.06.036","article-title":"A Biomimetic Peptide-Drug Supramolecular Hydrogel as Eyedrops Enables Controlled Release of Ophthalmic Drugs","volume":"167","author":"Pan","year":"2023","journal-title":"Acta Biomater."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.addr.2021.05.010","article-title":"Peptide-Based Supramolecular Hydrogels for Local Drug Delivery","volume":"174","author":"Zhang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1039\/D5FD00044K","article-title":"Spiers Memorial Lecture: Recent Advances (and Challenges) in Supramolecular Gels","volume":"260","author":"Zheng","year":"2025","journal-title":"Faraday Discuss."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"114171","DOI":"10.1016\/j.jconrel.2025.114171","article-title":"Natural Biomaterials for Contact Lens-Based Ophthalmic Drug Delivery Systems","volume":"387","author":"Pham","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/jop.2023.0111","article-title":"Sustained Delivery of Olopatadine from Vitamin-E Loaded Contact Lenses","volume":"40","author":"Reis","year":"2024","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"106511","DOI":"10.1016\/j.jddst.2024.106511","article-title":"NVP-Based Molecularly Imprinted Hydrogel Contact Lenses for Sustained Delivery of Naringenin: In Vitro, Ex Vivo, Cytocompatibility, Anti-Inflammatory and ISO Standardized Physicochemical Evaluation","volume":"104","author":"Faran","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Barcena, A.J.R., Dhal, K., Patel, P., Ravi, P., Kundu, S., and Tappa, K. (2023). Current Biomedical Applications of 3D-Printed Hydrogels. Gels, 10.","DOI":"10.3390\/gels10010008"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e18446","DOI":"10.1002\/adfm.202518446","article-title":"Wearable Contact Lenses for Advanced Ocular Drug Delivery: Progress and Challenges","volume":"36","author":"Wang","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1021\/acssensors.5c01222","article-title":"Optical Contact Lenses Biosensors","volume":"10","author":"Xia","year":"2025","journal-title":"ACS Sens."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1872210517666230731102130","article-title":"Nanocomposite Hydrogels: An Optimistic Insight Towards the Treatments of Ocular Disorders","volume":"19","author":"Shah","year":"2025","journal-title":"Recent Pat. Nanotechnol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"101767","DOI":"10.1016\/j.mtbio.2025.101767","article-title":"Intraocular Injectable Hydrogels for the Delivery of Cells and Nanoparticles","volume":"32","author":"Alonso","year":"2025","journal-title":"Mater. Today Bio"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"331","DOI":"10.37349\/ebmx.2024.00023","article-title":"Advancements in Hydrogel Technology for Ocular Drug Delivery","volume":"1","author":"Truong","year":"2024","journal-title":"Explor. BioMat-X"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/08164622.2025.2492761","article-title":"Drug Releasing Contact Lenses and Their Application to Disease Presentations","volume":"109","author":"Phan","year":"2026","journal-title":"Clin. Exp. Optom."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Rykowska, I., Nowak, I., Nowak, R., and Micha\u0142kiewicz, O. (2025). Biodegradable Contact Lenses for Targeted Ocular Drug Delivery: Recent Advances, Clinical Applications, and Translational Perspectives. Molecules, 30.","DOI":"10.3390\/molecules30122542"},{"key":"ref_122","unstructured":"Mandal, A., Dutta, A., Rudra, A., Mandal, A., Dutta, A., Rudra, A., Mandal, A., Dutta, A., and Rudra, A. (2024). A Comprehensive Review On Ophthalmic In Situ Gelling System. Am. J. PharmTech Res., 14."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"E22113525361929","DOI":"10.2174\/0122113525361929250127060448","article-title":"In Situ Gelling Systems for the Treatment of Ocular Pain and Inflammation: A Review","volume":"23","author":"Chouhan","year":"2025","journal-title":"Anti-Infect. Agents"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"126058","DOI":"10.1016\/j.ijpharm.2025.126058","article-title":"Long Acting Injectables & Implants: Advances in Intraocular Drug Delivery","volume":"683","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_125","unstructured":"Paredes, A.J., Larra\u00f1eta, E., Laverty, G., and Donnelly, R.F. (2025). Chapter 7\u2014Injectable Depot-Forming Hydrogels for Long-Acting Drug Delivery. Hydrogels in Drug Delivery, Elsevier."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"15077","DOI":"10.1007\/s10853-024-10103-x","article-title":"A Review of Recent Advances in Drug Loading, Mathematical Modeling and Applications of Hydrogel Drug Delivery Systems","volume":"59","author":"Hu","year":"2024","journal-title":"J. Mater. Sci."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Zhang, C., Wang, J., Wu, H., Fan, W., Li, S., Wei, D., Song, Z., and Tao, Y. (2024). Hydrogel-Based Therapy for Age-Related Macular Degeneration: Current Innovations, Impediments, and Future Perspectives. Gels, 10.","DOI":"10.3390\/gels10030158"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/bs.pmbts.2024.08.003","article-title":"Chapter Eight\u2014Delivery of Therapeutic Proteins to Ocular Tissues: Barriers, Approaches, Regulatory Considerations and Future Perspectives","volume":"Volume 212","author":"Teplow","year":"2025","journal-title":"Protein and Peptide Therapeutics"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Shastri, D.H., Silva, A.C., and Almeida, H. (2023). Ocular Delivery of Therapeutic Proteins: A Review. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010205"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/8\/981\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:44:02Z","timestamp":1786362242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/8\/981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":129,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["pharmaceutics18080981"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18080981","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,9]]}}}